A Comparative Trial of Standard 12 Lead ECG to the 12 Lead ECG Glove to Assess Cardiac Electrical Function

Completed

Conditions studied: Cardiac Electrical Function

In brief

The proposed study is a two-arm, randomized, single-blinded, cross-over Phase III clinical trial in which patients in 3 distinct clinical scenarios will receive the 12LEG, followed by the standard ECG, or vice-versa. Each participant will then apply the Hand ECG themselves. The 3 clinical scenarios will be: 1. patients at preoperative assessment for elective cardiac catheterization or electrophysiology procedures; 2. patients coming for outpatient cardiology appointments; 3. Inpatients admitted with a cardiac diagnosis. The electrophysiologists reviewing ECGs will be blinded to the equipment utilized to obtain the ECG.

Key facts

Study ID

NCT01218334

Run by

NYU Langone Health

People needed

300

Starts

2008-06-01

Expected to finish

2012-02-01

Last updated by the study team

2017-11-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Preop assessment for elective cardiac catheterization or EP procedure.
• Outpatient cardiology appointments.
• Inpatients admitted with a cardiac diagnosis

You may not qualify if…

• Age less than 18.
• Skin breakdown.

Where it is running

• New York University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.